Optimized in vivo detection of dopamine release using 18F-fallypride PET. 2012

Jenny Ceccarini, and Elske Vrieze, and Michel Koole, and Tom Muylle, and Guy Bormans, and Stephan Claes, and Koen Van Laere
Division of Nuclear Medicine, University Hospital and Katholieke Universiteit, Leuven, Belgium. jenny.ceccarini@uz.kuleuven.be

The high-affinity D(2/3) PET radioligand (18)F-fallypride offers the possibility of measuring both striatal and extrastriatal dopamine release during activation paradigms. When a single (18)F-fallypride scanning protocol is used, task timing is critical to the ability to explore both striatal and extrastriatal dopamine release simultaneously. We evaluated the sensitivity and optimal timing of task administration for a single (18)F-fallypride PET protocol and the linearized simplified reference region kinetic model in detecting both striatal and extrastriatal reward-induced dopamine release, using human and simulation studies. METHODS Ten healthy volunteers underwent a single-bolus (18)F-fallypride PET protocol. A reward responsiveness learning task was initiated at 100 min after injection. PET data were analyzed using the linearized simplified reference region model, which accounts for time-dependent changes in (18)F-fallypride displacement. Voxel-based statistical maps, reflecting task-induced D(2/3) ligand displacement, and volume-of-interest-based analysis were performed to localize areas with increased ligand displacement after task initiation, thought to be proportional to changes in endogenous dopamine release (γ parameter). Simulated time-activity curves for baseline and hypothetical dopamine release functions (different peak heights of dopamine and task timings) were generated using the enhanced receptor-binding kinetic model to investigate γ as a function of these parameters. RESULTS The reward task induced increased ligand displacement in extrastriatal regions of the reward circuit, including the medial orbitofrontal cortex, ventromedial prefrontal cortex, and dorsal anterior cingulate cortex. For task timing of 100 min, ligand displacement was found for the striatum only when peak height of dopamine was greater than 240 nM, whereas for frontal regions, γ was always positive for all task timings and peak heights of dopamine. Simulation results for a peak height of dopamine of 200 nM showed that an effect of striatal ligand displacement could be detected only when task timing was greater than 120 min. CONCLUSIONS The prefrontal and anterior cingulate cortices are involved in reward responsiveness that can be measured using (18)F-fallypride PET in a single scanning session. To measure both striatal and extrastriatal dopamine release, the height of dopamine released and task timing need to be considered in designing activation studies depending on regional D(2/3) density.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001549 Benzamides BENZOIC ACID amides.
D012201 Reward An object or a situation that can serve to reinforce a response, to satisfy a motive, or to afford pleasure. Rewards
D017072 Neostriatum The phylogenetically newer part of the CORPUS STRIATUM consisting of the CAUDATE NUCLEUS and PUTAMEN. It is often called simply the striatum.

Related Publications

Jenny Ceccarini, and Elske Vrieze, and Michel Koole, and Tom Muylle, and Guy Bormans, and Stephan Claes, and Koen Van Laere
October 2017, Drug and alcohol dependence,
Jenny Ceccarini, and Elske Vrieze, and Michel Koole, and Tom Muylle, and Guy Bormans, and Stephan Claes, and Koen Van Laere
August 2014, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Jenny Ceccarini, and Elske Vrieze, and Michel Koole, and Tom Muylle, and Guy Bormans, and Stephan Claes, and Koen Van Laere
February 2019, Psychopharmacology,
Jenny Ceccarini, and Elske Vrieze, and Michel Koole, and Tom Muylle, and Guy Bormans, and Stephan Claes, and Koen Van Laere
December 2013, Synapse (New York, N.Y.),
Jenny Ceccarini, and Elske Vrieze, and Michel Koole, and Tom Muylle, and Guy Bormans, and Stephan Claes, and Koen Van Laere
December 2012, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
Jenny Ceccarini, and Elske Vrieze, and Michel Koole, and Tom Muylle, and Guy Bormans, and Stephan Claes, and Koen Van Laere
July 2011, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Jenny Ceccarini, and Elske Vrieze, and Michel Koole, and Tom Muylle, and Guy Bormans, and Stephan Claes, and Koen Van Laere
March 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Jenny Ceccarini, and Elske Vrieze, and Michel Koole, and Tom Muylle, and Guy Bormans, and Stephan Claes, and Koen Van Laere
May 2010, Synapse (New York, N.Y.),
Jenny Ceccarini, and Elske Vrieze, and Michel Koole, and Tom Muylle, and Guy Bormans, and Stephan Claes, and Koen Van Laere
August 2006, Epilepsia,
Jenny Ceccarini, and Elske Vrieze, and Michel Koole, and Tom Muylle, and Guy Bormans, and Stephan Claes, and Koen Van Laere
April 2015, Psychiatry research,
Copied contents to your clipboard!